BamSEC and AlphaSense Join Forces
Learn More

BioCryst Pharmaceuticals Inc.

NASDAQ: BCRX    
Share price (1/2/26): $7.50    
Market cap (1/2/26): $1.581 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-Q 9 pages Consulting Agreement
12/34/56
EX-10.3
from 10-Q 12 pages Material contract
12/34/56
EX-10.5
from 8-K 23 pages Trademark License Agreement Dated as of October 1, 2025 by and Between BioCryst Pharmaceuticals, Inc., as Licensor, and BioCryst Ireland Limited, as Licensee
12/34/56
EX-10.4
from 8-K 32 pages Transition Services Agreement Dated as of October 1, 2025 by and Between BioCryst Pharmaceuticals, Inc., as Seller, and BioCryst Ireland Limited, as Company
12/34/56
EX-10.3
from 8-K 35 pages Global Brand and Support Agreement Dated as of October 1, 2025 by and Between BioCryst Pharmaceuticals, Inc., as the Seller, and BioCryst Ireland Limited, as the Company
12/34/56
EX-10.2
from 8-K 32 pages Supply Agreement Dated as of October 1, 2025 by and Between BioCryst Pharmaceuticals, Inc., as Supplier, and BioCryst Ireland Limited, as Recipient
12/34/56
EX-10.1
from 8-K 30 pages Amended and Restated Ip Licence Agreement Dated as of October 1, 2025 by and Between BioCryst Pharmaceuticals, Inc., as the Licensor, and BioCryst Ireland Limited, as the Licensee
12/34/56
EX-10.4
from 10-Q 3 pages Second Amendment to Employment Agreement
12/34/56
EX-10.3
from 10-Q 20 pages Amended and Restated Employment Agreement
12/34/56
EX-10.2
from 10-Q 1 page Amendment to Consulting Agreement
12/34/56
EX-10.1
from 8-K 22 pages BioCryst Pharmaceuticals, Inc. Stock Incentive Plan
12/34/56
EX-10.3
from 10-Q 3 pages BioCryst Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy Effective April 21, 2025
12/34/56
EX-10.2
from 10-Q 7 pages BioCryst Pharmaceuticals, Inc. Notice of Grant of Stock Option
12/34/56
EX-10.1
from 10-Q 4 pages Consulting Agreement
12/34/56
EX-10.50
from 10-K 5 pages Joinder Agreement
12/34/56
EX-10.1
from 10-Q 2 pages BioCryst Pharmaceuticals, Inc. Equity Award Retirement Policy Effective Date: July 1, 2024
12/34/56
EX-10.4
from 10-Q 6 pages Biocryst Pharmaceuticals, Inc. Stock Incentive Plan Notice of Performance-Based Restricted Stock Unit Award
12/34/56
EX-10.3
from 10-Q 2 pages Biocryst Pharmaceuticals, Inc. Equity Award Retirement Policy Effective Date: July 1, 2024
12/34/56
EX-10.2
from 10-Q 1 page First Amendment to the Biocryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 23 pages Biocryst Pharmaceuticals, Inc. Stock Incentive Plan
12/34/56